Interaction of Angiogenically Stimulated Intermediate CD163+ Monocytes/Macrophages With Soft Hydrophobic Poly(n-Butyl Acrylate) Networks With Elastic Moduli Matched to That of Human Arteries

Artificial Organs

Volumn 36, Issue 3, 2012, Pages

  Mayer, Anke ^a   Kratz, Karl ^a   Hiebl, Bernhard ^a   Lendlein, Andreas ^a   Jung, Friedrich ^a  

^a INSTITUTE OF MATERIALS RESEARCH   (Germany)

Author keywords

Biomaterial; Cytokine delivery system; Elasticity; Intermediate; Monocytes; Poly(n butyl acrylate); Vascular endothelial growth factor

Indexed keywords

BIOMATERIALS; BODY FLUIDS; CELL CULTURE; CELL ENGINEERING; CELL PROLIFERATION; ELASTIC MODULI; ENDOTHELIAL CELLS; ETHYLENE; HYDROGELS; HYDROPHOBICITY; SURFACE ROUGHNESS;

CYTOKINE DELIVERY; CYTOKINE DELIVERY SYSTEM; DELIVERY SYSTEMS; HYDROPHOBICS; INTERMEDIATE; MONOCYTE; MONOCYTE-MACROPHAGES; POLY(N-BUTYL ACRYLATE); VASCULAR ENDOTHELIAL GROWTH FACTOR;

ELASTICITY;

CD163 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; POLY(N BUTYL ACRYLATE); POLYMER; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN A;

ANGIOGENESIS; ANTIGEN EXPRESSION; ARTICLE; CD163++ MONOCYTE MACROPHAGE; CELL ADHESION; CELL DENSITY; CELL STRUCTURE; CELL SUBPOPULATION; CYTOKINE RELEASE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYDROPHOBICITY; MONOCYTE MACROPHAGE PRECURSOR CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; YOUNG MODULUS;

EID: 84858006196     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2011.01410.x     Document Type: Article

References (52)

1. Grage-Griebenow E, Flad H-D, Ernst M. Heterogeneity of human peripheral blood monocyte subsets. J Leukoc Biol 2001;69:11-20.
2. Ziegler-Heitbrock L, Ancuta P, Crowe S, etal. Nomenclature of monocytes and dendritic cells in blood. Blood 2010;116:e74-80.
3. Belge KU, Dayyani F, Horelt A, etal. The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF. J Immunol 2002;168:3536-42.
4. Frankenberger M, Sternsdorf T, Pechumer H, Pforte A, Ziegler-Heitbrock HW. Differential cytokine expression in human blood monocyte subpopulations: a polymerase chain reaction analysis. Blood 1996;87:373-7.
5. Skrzeczyńska-Moncznik J, Bzowska M, Loseke S, Grage-Griebenow E, Zembala M, Pryjma J. Peripheral blood CD14high CD16+ monocytes are main producers of IL-10. Scand J Immunol 2008;67:152-9.
6. Buechler C, Ritter M, Orso E, Langmann T, Klucken J, Schmitz G. Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli. J Leukoc Biol 2000;67:97-103.
7. Backe E, Schwarting R, Gerdes J, Ernst M, Stein H. Ber-MAC3: new monoclonal antibody that defines human monocyte/macrophage differentiation antigen. J Clin Pathol 1991;44:936-45.
8. Pulford K, Micklem K, McCarthy S, Cordell J, Jones M, Mason DY. A monocyte/macrophage antigen recognized by the four antibodies GHI/61, Ber-MAC3, Ki-M8 and SM4. Immunology 1992;75:588-95.
9. Van Gorp H, Delputte PL, Nauwynck HJ. Scavenger receptor CD163, a Jack-of-all-trades and potential target for cell-directed therapy. Mol Immunol 2010;47:1650-60.
10. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004;25:677-86.
11. Akeson A, Herman A, Wiginton D, Greenberg J. Endothelial cell activation in a VEGF-A gradient: relevance to cell fate decisions. Microvasc Res 2010;80:65-74.
12. Xue L, Greisler HP. Angiogenic effect of fibroblast growth factor-1 and vascular endothelial growth factor and their synergism in a novel in vitro quantitative fibrin-based 3-dimensional angiogenesis system. Surgery 2002;132:259-67.
13. Patterson C, Runge MS. Therapeutic myocardial angiogenesis via vascular endothelial growth factor gene therapy: moving on down the road. Circulation 2000;102:940-2.
14. Mayer A, Lee S, Jung F, Gruetz G, Lendlein A, Hiebl B. CD14+ CD163+ IL-10+ monocytes/macrophages: pro-angiogenic and non pro-inflammatory isolation, enrichment and long term secretion profile. Clin Hemorheol Microcirc 2010;46:217-23.
15. Shastri VP, Lendlein A. Materials in regenerative medicine. Adv Mater 2009;21:3231-4.
16. Weigel T, Schinkel G, Lendlein A. Design and preparation of polymeric scaffolds for tissue engineering. Expert Rev Med Devices 2006;3:835-51.
17. Hoepken S, Fuhrmann R, Jung F, Franke RP. Shear resistance of human umbilical endothelial cells on different materials covered with or without extracellular matrix: controlled in-vitro study. Clin Hemorheol Microcirc 2009;43:157-66.
18. Coyle CH, Mendralla S, Lanasa S, Kader KN. Endothelial cell seeding onto various biomaterials causes superoxide-induced cell death. J Biomater Appl 2007;22:55-69.
19. Jung F, Wischke C, Lendlein A. Degradable, multifunctional cardiovascular implants: challenges and hurdles. MRS Bull 2010;35:607-13.
20. Zócalo Y, Bia D, Armentano RL, etal. Vascular cryografts offer better biomechanical properties in chronically hemodialyzed patients: role of cryograft type, arterial pathway, and diabetic nephropathy as matching determinants. Artif Organs 2010;34:677-84.
21. Patel DJ, Janicki JS, Carew TE. Static anisotropic elastic properties of the aorta in living dogs. Circ Res 1969;25:765-79.
22. Patel DJ, Janicki JS. Static elastic properties of the left coronary circumflex artery and the common carotid artery in dogs. Circ Res 1970;27:149-58.
23. Riley WA, Barnes RW, Evans GW, Burke GL. Ultrasonic measurement of the elastic modulus of the common carotid artery. The Atherosclerosis Risk in Communities (ARIC) Study. Stroke 1992;23:952-6.
24. Hiebl B, Cui J, Kratz K, etal. Viability, morphology and function of primary endothelial cells on poly(n-butyl acrylate) networks having elastic moduli comparable to arteries. J Biomater Sci Polym Ed 2011; Epub Mar 31, DOI:10.1163/092050611X566144.
25. Dinarello CA. IL-1: discoveries, controversies and future directions. Eur J Immunol 2010;40:599-606.
26. Kaplanski G, Marin V, Montero-Julian F, Mantovani A, Farnarier C. IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation. Trends Immunol 2003;24:25-9.
27. Wahl SM. Transforming growth factor beta: the good, the bad, and the ugly. J Exp Med 1994;180:1587-90.
28. Cui J, Kratz K, Hiebl B, Jung F, Lendlein A. Soft poly(n-butyl acrylate) networks with tailored mechanical properties designed as substrates for in vitro models. Polym Adv Technol 2011;22:126-32.
29. MacEwan MR, Brodbeck WG, Matsuda T, Anderson JM. Student Research Award in the Undergraduate Degree Candidate category, 30th Annual Meeting of the Society for Biomaterials, Memphis, Tennessee, April 27-30, 2005. Monocyte/lymphocyte interactions and the foreign body response: in vitro effects of biomaterial surface chemistry. J Biomed Mater Res A 2005;74:285-93.
30. Shen M, Horbett TA. The effects of surface chemistry and adsorbed proteins on monocyte/macrophage adhesion to chemically modified polystyrene surfaces. J Biomed Mater Res 2001;57:336-45.
31. Bergstrom K, Osterberg E, Holmberg K, etal. Effects of branching and molecular weight of surface-bound poly(ethylene oxide) on protein rejection. J Biomater Sci Polym Ed 1994;6:123-32.
32. Cima LG. Polymer substrates for controlled biological interactions. J Cell Biochem 1994;56:155-61.
33. Brodbeck WG, Shive MS, Colton E, Nakayama Y, Matsuda T, Anderson JM. Influence of biomaterial surface chemistry on the apoptosis of adherent cells. J Biomed Mater Res 2001;55:661-8.
34. Brodbeck WG, Patel J, Voskerician G, etal. Biomaterial adherent macrophage apoptosis is increased by hydrophilic and anionic substrates in vivo. Proc Natl Acad Sci U S A 2002;99:10287-92.
35. Hayashi T, Tanaka M, Yamamoto S, Shimomura M, Hara M. Direct observation of interaction between proteins and blood-compatible polymer surfaces. Biointerphases 2007;2:119-25.
36. George ML, Eccles SA, Tutton MG, Abulafi AM, Swift RI. Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging? Clin Cancer Res 2000;6:3147-52.
37. Gratchev A, Kzhyshkowska J, Kothe K, etal. Mphi1 and Mphi2 can be re-polarized by Th2 or Th1 cytokines, respectively, and respond to exogenous danger signals. Immunobiology 2006;211:473-86.
38. Goldbach-Mansky R. Blocking interleukin-1 in rheumatic diseases. Ann N Y Acad Sci 2009;1182:111-23.
39. Abramson SB, Amin A. Blocking the effects of IL-1 in rheumatoid arthritis protects bone and cartilage. Rheumatology (Oxford) 2002;41:972-80.
40. de Waal Malefyt R, Figdor CG, Huijbens R, etal. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-gamma or IL-10. J Immunol 1993;151:6370-81.
41. Gerber JS, Mosser DM. Reversing lipopolysaccharide toxicity by ligating the macrophage Fc{{gamma}} receptors. J Immunol 2001;166:6861-8.
42. Davignon JL, Cohen PL, Eisenberg RA. Immunological effects of recombinant interferon gamma in vivo in normal mice: failure to induce autoantibodies. Int J Immunopharmacol 1990;12:691-8.
43. Cornelissen AM, Maltha JC, Von den Hoff JW, Kuijpers-Jagtman AM. Local injection of IFN-gamma reduces the number of myofibroblasts and the collagen content in palatal wounds. J Dent Res 2000;79:1782-8.
44. Alikhani M, Alikhani Z, Raptis M, Graves DT. TNF-alpha in vivo stimulates apoptosis in fibroblasts through caspase-8 activation and modulates the expression of pro-apoptotic genes. J Cell Physiol 2004;201:341-8.
45. Worrall NK, Chang K, LeJeune WS, etal. TNF-alpha causes reversible in vivo systemic vascular barrier dysfunction via NO-dependent and -independent mechanisms. Am J Physiol 1997;273:2565-74.
46. DeFail AJ, Chu CR, Izzo N, Marra KG. Controlled release of bioactive TGF-beta 1 from microspheres embedded within biodegradable hydrogels. Biomaterials 2006;27:1579-85.
47. Hao X, Månsson-Broberg A, Gustafsson T, etal. Angiogenic effects of dual gene transfer of bFGF and PDGF-BB after myocardial infarction. Biochem Biophys Res Commun 2004;315:1058-63.
48. Heldin CH, Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 1999;79:1283-316.
49. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003;3:23-35.
50. Kodelja V, Muller C, Tenorio S, Schebesch C, Orfanos CE, Goerdt S. Differences in angiogenic potential of classically vs. alternatively activated macrophages. Immunobiology 1997;197:478-93.
51. Hiebl B, Bog S, Mrowietz C, etal. Influence of VEGF stimulated human macrophages on the proliferation of dermal microvascular endothelial cells: coculture experiments. Clin Hemorheol Microcirc 2010;46:211-16.
52. Greenwald SE, Berry CL. Improving vascular grafts: the importance of mechanical and haemodynamic properties. J Pathol 2000;190:292-9.